Cargando…
Transdermal delivery of combined hormonal contraception: a review of the current literature
The transdermal patch provides an effective and convenient option for hormonal contraception. The patch currently on the US market contains 150 µg norelgestromin and 35 µg ethinylestradiol (EE). The 20 cm(2) patch is applied once weekly for 3 weeks, followed by a patch-free week, for a 21–7 cycle. T...
Autores principales: | Galzote, Rosanna M, Rafie, Sally, Teal, Rachel, Mody, Sheila K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440026/ https://www.ncbi.nlm.nih.gov/pubmed/28553144 http://dx.doi.org/10.2147/IJWH.S102306 |
Ejemplares similares
-
Access to contraception in pharmacies during the COVID-19 pandemic
por: Siddiqui, Nawal, et al.
Publicado: (2021) -
Pharmacist Outlooks on Prescribing Hormonal Contraception Following Statewide Scope of Practice Expansion
por: Rafie, Sally, et al.
Publicado: (2019) -
Role of the community pharmacist in emergency contraception counseling and delivery in the United States: current trends and future prospects
por: Rafie, Sally, et al.
Publicado: (2017) -
Pharmacy Implementation of a New Law Allowing Year-Long Hormonal Contraception Supplies
por: Nikpour, Gelareh, et al.
Publicado: (2020) -
Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review
por: Graziottin, Alessandra
Publicado: (2008)